Tag: Dei Biopharm Vaccines Plant seeks UGX 1.8 trillion from government

Dr. Matthias Magoola is leading the charge on using mRNA technology to make affordable human medicines and vaccines KAMPALA - ...

MPs pictured inside the YKTM GLP Biotech Laboratories, which is now ready MATUGGA - Members of Parliament's Health Committee have ...

Dei Biopharm's state-of-the-art vaccine manufacturing facility has received prestigious NDA accreditation, marking a significant milestone in the company's commitment to ...

Dr. Matthias Magoola has commended President Museveni for his unwavering support to scientists KAMPALA – Dr. Matthias Magoola, the founder and Chief ...

Dei Group of Companies Chief Executive and Founder Dr. Matthias Magoola was recognized at the coronation ceremony as the leading ...

Low cost drugs. The multi-million dollar biological drugs and vaccines manufacturing facility in Mattuga, Wakiso, Uganda being developed by Dei ...

Uganda government has agreed to inject UGX. 18 trillion into Dei Biopharm Vaccines Plant in Matugga (PHOTO/Courtesy). MATUGGA —Uganda risks ...